Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1490 Articles

Chris Lange | Aug 12, 2015 at 9:45 AM EDT

Short Sellers Back Off Big Pharma

The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical…

Jon C. Ogg | Aug 10, 2015 at 12:25 PM EDT

5 Defensive High-Yield Dividends That Should Withstand the Next Stock Market Correction

24/7 Wall St. maintains on its watch list a slew of defensive dividend stocks that investors flock to during periods…

Paul Ausick | Aug 6, 2015 at 4:01 PM EDT

The 4 Stocks That Dragged Down the DJIA on Thursday

thinkstockAugust 6, 2015: Markets opened higher again on Thursday but not by much and equities quickly turned south and remained…

Lee Jackson | Aug 6, 2015 at 8:35 AM EDT

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term…

Lee Jackson | Jul 31, 2015 at 10:05 AM EDT

4 Merrill Lynch Big, Old and Ugly Stocks to Buy for the Rest of 2015

ThinkstockFor the most part, unless you were way over-weighted to energy, large cap and mega cap stocks did reasonably well…

Jon C. Ogg | Jul 29, 2015 at 8:54 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

Jon OggStocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday’s rally was yet…

Paul Ausick | Jul 28, 2015 at 4:01 PM EDT

The 4 Stocks That Lifted the Dow on Tuesday

thinkstockJuly 28, 2015: Markets opened higher on Tuesday after the Shanghai market closed with a modest loss compared with Monday’s…

Paul Ausick | Jul 28, 2015 at 7:42 AM EDT

Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs

ThinkstockPfizer Inc. (NYSE: PFE) reported second quarter 2015 results before markets opened Tuesday morning. The company reported quarterly adjusted diluted…

Paul Ausick | Jul 27, 2015 at 2:17 PM EDT

What to Look For in Pfizer Earnings

Wikimedia CommonsBefore the market opens on Tuesday morning, Pfizer Inc. (NYSE: PFE) is scheduled to report second-quarter results. The company…

Chris Lange | Jul 27, 2015 at 8:21 AM EDT

Short Sellers Run For Cover From Major Pharma

ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a…

Jon C. Ogg | Jul 26, 2015 at 10:21 AM EDT

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings…

Lee Jackson | Jul 14, 2015 at 10:20 AM EDT

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for…

Chris Lange | Jul 13, 2015 at 8:05 AM EDT

Short Sellers Run for Cover in Big Pharma

The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short…

Paul Ausick | Jul 9, 2015 at 4:01 PM EDT

The 4 Stocks That Boosted the DJIA on Thursday

thinkstockJuly 9, 2015: Markets opened higher on Thursday and that’s when the major indexes posted their daily highs. New claims…

Lee Jackson | Jul 8, 2015 at 8:55 AM EDT

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay…

1 … 58 59 60 61 62 … 100

Pfizer : PFE

All Pfizer Articles

Short Sellers Back Off Big Pharma

5 Defensive High-Yield Dividends That Should Withstand the Next Stock Market Correction

The 4 Stocks That Dragged Down the DJIA on Thursday

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

4 Merrill Lynch Big, Old and Ugly Stocks to Buy for the Rest of 2015

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

The 4 Stocks That Lifted the Dow on Tuesday

Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs

What to Look For in Pfizer Earnings

Short Sellers Run For Cover From Major Pharma

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Short Sellers Run for Cover in Big Pharma

The 4 Stocks That Boosted the DJIA on Thursday

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

If CLARITY Clears the Senate by August, Where Does XRP Trade by Q4?

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

Pfizer : PFE

All Pfizer Articles

Short Sellers Back Off Big Pharma

5 Defensive High-Yield Dividends That Should Withstand the Next Stock Market Correction

The 4 Stocks That Dragged Down the DJIA on Thursday

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

4 Merrill Lynch Big, Old and Ugly Stocks to Buy for the Rest of 2015

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

The 4 Stocks That Lifted the Dow on Tuesday

Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs

What to Look For in Pfizer Earnings

Short Sellers Run For Cover From Major Pharma

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Short Sellers Run for Cover in Big Pharma

The 4 Stocks That Boosted the DJIA on Thursday

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

If CLARITY Clears the Senate by August, Where Does XRP Trade by Q4?

Featured Reads

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On